為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

限制級
您即將進入之新聞內容 需滿18歲 方可瀏覽。
根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

《TAIPEI TIMES》 NHI may cover cancer gene testing


National Health Insurance Administration Director-General Shih Chung-liang talks to reporters in Taipei yesterday.
Photo: CNA

National Health Insurance Administration Director-General Shih Chung-liang talks to reporters in Taipei yesterday. Photo: CNA

2024/01/22 03:00

LIMITS: While people can pay out of pocket for some of the next-generation sequencing tests, to receive NHI coverage, they must share the results with the agency

By Lin Hui-chin / Staff reporter

Next-generation sequencing tests for precision cancer therapy might be covered by the National Health Insurance (NHI) from May, National Health Insurance Administration Director-General Shih Chung-liang (石崇良) said yesterday.

About 830,000 people sought medical treatment for cancer in 2022, and the total NHI drug expense was about NT$39.2 billion (US$1.25 billion), of which 61.7 percent was spent on targeted therapy, Shih said while attending a conference on next-generation sequencing held by Taiwan Precision Medicine Society in Taipei.

The NHI covers 26 types of targeted therapy, aimed at 11 gene loci (fixed positions on a chromosome) and for the treatment of 10 types of cancer, he said.

Coverage for next-generation sequencing would mainly be for gene locus testing, he added.

The technology can examine multiple gene loci at once for 19 types of cancer, including non-small cell lung cancer, triple-negative breast cancer, ovarian cancer, fallopian tube cancer, intrahepatic cholangiocarcinoma (bile duct cancer of the liver), primary peritoneal cancer and prostate cancer.

The NHI plan would include three types of payment models: an independent payment for longer gene segments of the breast cancer 1 and breast cancer 2 genes, payment for a small set of fewer than 100 genes based on the most basic gene loci of each type of cancer, and payment for a large set of more than 100 gene loci, Shih said, adding that people can pay the difference in cost out of pocket according to their personal needs.

To be covered, the test results must be uploaded to the National Health Research Institutes’ database, he said.

Issues concerning the NHI-covered tests would be discussed in a specialists meeting on Feb. 6, and hopefully the policy can take effect in May or June, he said, adding that it is expected to cost about NT$600 million to NT$1 billion, and the budget might be expanded next year if possible.

新聞來源:TAIPEI TIMES

不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

焦點今日熱門
看更多!請加入自由時報粉絲團

網友回應

載入中
此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。